PRF Technologies (PRFX) EPS (Basic) (2020 - 2024)
PRF Technologies' (PRFX) quarterly EPS (Basic) came in at -$221.67 in Q2 2024, up 19.39% YoY from -$185.66 in Q3 2023, and up 35.66% on a QoQ basis from -$344.55 in Q1 2024.
PRF Technologies (PRFX) EPS (Basic) (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of EPS (Basic) data on file, last reported at -$221.67 in Q2 2024.
- Quarterly EPS (Basic) rose 19.39% year-over-year to -$221.67 in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$11.73 (up 95.6% YoY) and the FY2025 annual result came in at -$7.75, up 95.26% from the prior year.
- EPS (Basic) climbed to -$221.67 in Q2 2024, from -$344.55 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$157.25 in Q3 2023 to a low of -$3314.6 in Q1 2020.
- A 5-year average of -$726.25 and a median of -$286.43 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) surged 91.84% — and 2023, when it plunged 36.36%.
- Tracing PRFX's EPS (Basic) over 5 years: stood at -$1541.6 in 2020, then soared by 45.32% to -$842.97 in 2021, then fell by 18.51% to -$998.99 in 2022, then gained by 1.44% to -$984.6 in 2023, then surged by 77.49% to -$221.67 in 2024.
- The last three EPS (Basic) figures came in at -$221.67 (Q2 2024), -$344.55 (Q1 2024), and -$984.6 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -221.67 |
| Mar 31, 2024 | -344.55 |
| Dec 31, 2023 | -984.60 |
| Sep 30, 2023 | -157.25 |
| Jun 30, 2023 | -275.01 |
| Mar 31, 2023 | -297.85 |
| Dec 31, 2022 | -998.99 |
| Sep 30, 2022 | -263.60 |
| Jun 30, 2022 | -235.05 |
| Mar 31, 2022 | -218.43 |
| Dec 31, 2021 | -842.97 |
| Sep 30, 2021 | -246.12 |
| Jun 30, 2021 | -235.91 |
| Mar 31, 2021 | -270.58 |
| Dec 31, 2020 | -1,541.62 |
| Sep 30, 2020 | -605.01 |
| Jun 30, 2020 | -2,018.75 |
| Mar 31, 2020 | -3,314.58 |